Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A Jul 21, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Incannex Healthcare Limited (ASX:IHL) Amended Loyalty Options Timetable Mar 21, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
